Evidence map›Paper›PMID 36878637›Full record

ArticleLife science alliance2023

Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies.

Priya Saikumar Lakshmi, Cliff I Oduor, Catherine S Forconi, Viriato M'Bana, Courtney Bly, Rachel M Gerstein, Juliana A Otieno, John M Ong'echa, Christian Münz, Micah A Luftig and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Priya Saikumar LakshmiDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Cliff I OduorDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Catherine S ForconiDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Viriato M'BanaDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Courtney BlyDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Rachel M GersteinDepartment of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Juliana A OtienoJaramogi Oginga Odinga Teaching and Referral Hospital, Ministry of Medical Services, Kisumu, Kenya.
John M Ong'echaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.ORCID https://orcid.org/0000-0003-3928-6774
Christian MünzDepartment of Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland.
Micah A LuftigDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA.
Michael A BrehmProgram in Molecular Medicine and the Diabetes Center of Excellence, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0001-6813-3262
Jeffrey A BaileyDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Ann M MoormannDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA ann.moormann@umassmed.edu.ORCID https://orcid.org/0000-0003-1113-2829

Funding

Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphomaR01CA189806 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORMANN, ANN M · 2014 to 2024
$5.7M
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesisR01CA234348 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 2019 to 2023
$3.3M
T Cell Immunity in Endemic Burkitt LymphomaR01CA134051 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORMANN, ANN M · 2008 to 2012
$2.3M
NCI NIH HHS R01 CA134051NCI NIH HHS R01 CA189806NCI NIH HHS R01 CA234348
6 · The paper itself

Abstract

Endemic Burkitt lymphoma (BL) is a childhood cancer in sub-Saharan Africa characterized by Epstein-Barr virus and malaria-associated aberrant B-cell activation and

Indexed as

Burkitt LymphomaEpstein-Barr Virus InfectionsAnimalsCell Line, TumorDisease Models, AnimalHerpesvirus 4, HumanMiceRituximabRituximab

Identifiers

PMID36878637
PMCPMC9990458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.